Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 HKD | 0.00% | -1.67% | -13.87% |
May. 31 | Chinese Regulators Accept Fusen Pharmaceutical’s Drug Application | MT |
Apr. 04 | Fusen Pharmaceutical's Type 2 Diabetes Drug Application Accepted by Chinese Regulator | MT |
Business Summary
Number of employees: 1,148
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Shuanghuanglian Oral Solutions
48.8
%
| 275 | 48.1 % | 305 | 48.8 % | +10.85% |
Others
17.9
%
| 136 | 23.8 % | 112 | 17.9 % | -17.97% |
Shuanghuanglian Injections
17.3
%
| 86 | 15.0 % | 108 | 17.3 % | +26.05% |
Heat-clearing and Detoxicating Oral Solutions
8.6
%
| - | - | 54 | 8.6 % | - |
Nicardipine Hydrochloride Injections
4.8
%
| - | - | 30 | 4.8 % | - |
Third-party Products
2.6
%
| 27 | 4.6 % | 17 | 2.6 % | -37.54% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 572 | 100.0 % | 625 | 100.0 % | +9.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 46 | 19-04-17 |
Zhi Ming Cao
BRD | Director/Board Member | 38 | 13-01-17 |
Tik Man Wong
SEC | Corporate Secretary | 43 | 21-01-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Tung Lee
BRD | Director/Board Member | 56 | 19-04-14 |
Chang Cheng Cao
CHM | Chairman | 67 | 16-11-19 |
Tai Sheng Hou
BRD | Director/Board Member | 61 | 17-04-06 |
Yong Sheng Chi
BRD | Director/Board Member | 62 | 17-04-06 |
Qing Fen Meng
BRD | Director/Board Member | 59 | 17-04-06 |
Zhi Ming Cao
BRD | Director/Board Member | 38 | 13-01-17 |
Wing Chun Sze
BRD | Director/Board Member | 47 | 18-05-31 |
Kit Wa To
BRD | Director/Board Member | 49 | 20-08-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 749,956,000 | 166,708,000 ( 22.23 %) | 0 | 22.23 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.87% | 112M | |
+16.93% | 42.79B | |
+22.20% | 22.81B | |
+15.82% | 15.04B | |
+18.51% | 14.49B | |
+51.63% | 12.65B | |
-0.05% | 6.79B | |
-11.45% | 6.74B | |
-8.87% | 5.73B | |
+14.55% | 5.47B |
- Stock Market
- Equities
- 1652 Stock
- Company Fusen Pharmaceutical Company Limited